Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
3187 |
|
| Actual shortage: | 261 (8%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 10 (0%) | |
| Resolved: | 2915 (91%) | |
Discontinuation Reports |
435 |
|
| To be discontinued: | 2 (0%) | |
| Discontinued: | 410 (94%) | |
| Reversed: | 23 (5%) | |
Late reports |
482 (13%) |
|
Overdue reports |
11 (4%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-LEVOFLOXACIN | 500MG | TABLET | Resolved | 2025-01-23 | 2025-09-02 | 248433 |
| ACT LOVASTATIN | 20MG | TABLET | Actual shortage | 2018-10-23 | 2019-03-14 | 65510 |
| ACT LOVASTATIN | 40MG | TABLET | Actual shortage | 2018-10-23 | 2019-03-14 | 65513 |
| ACT MELOXICAM | 7.5MG | TABLET | Actual shortage | 2020-01-09 | 2020-01-09 | 102935 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2020-07-23 | 2020-09-03 | 120917 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2020-09-11 | 2021-01-14 | 124098 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2020-10-15 | 2021-03-04 | 126513 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-01-19 | 2023-02-09 | 181588 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-04-27 | 2023-11-21 | 190680 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-06-16 | 2023-07-07 | 195180 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-11-30 | 2024-01-08 | 211998 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-11-30 | 2023-12-07 | 212001 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2023-12-14 | 2024-03-21 | 213374 |
| ACT MEMANTINE | 10MG | TABLET | Resolved | 2025-10-10 | 2025-11-13 | 269238 |
| TEVA-METFORMIN | 850MG | TABLET | Resolved | 2020-01-17 | 2020-10-22 | 103584 |
| TEVA-METFORMIN | 850MG | TABLET | Resolved | 2020-04-02 | 2020-05-14 | 110649 |
| TEVA-METFORMIN | 500MG | TABLET | Resolved | 2020-04-03 | 2020-06-04 | 110800 |
| TEVA-METFORMIN | 500MG | TABLET | Resolved | 2020-04-03 | 2020-05-14 | 110803 |
| TEVA-METFORMIN | 500MG | TABLET | Resolved | 2020-04-03 | 2020-04-23 | 110806 |
| TEVA-METFORMIN | 500MG | TABLET | Resolved | 2020-06-25 | 2020-08-27 | 118912 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-RANITIDINE SOLUTION | 15MG | SOLUTION | Discontinued | 2019-04-11 | 2019-04-11 | 81304 |
| TEVA-RASAGILINE | 1MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258753 |
| TEVA-RISEDRONATE | 150MG | TABLET | Discontinued | 2021-02-12 | 2021-02-12 | 133905 |
| TEVA-RISEDRONATE | 30MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256079 |
| TEVA-RISEDRONATE | 30MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258473 |
| TEVA-RISPERIDONE | 1MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258673 |
| TEVA-RISPERIDONE | 2MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258679 |
| TEVA-RISPERIDONE | 3MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258685 |
| TEVA-RISPERIDONE | 4MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258688 |
| TEVA-RISPERIDONE | 0.25MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258711 |
| TEVA-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157428 |
| TEVA-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157431 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157434 |
| TEVA-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2022-03-25 | 2022-03-26 | 157437 |
| TEVA-ROSUVASTATIN | 20MG | TABLET | Reversed | 2025-05-28 | 2025-06-04 | 258765 |
| TEVA-SPIRONOLACTONE | 100MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258486 |
| TEVA-SUCRALFATE | 1G | TABLET | Discontinued | 2025-09-02 | 2025-09-02 | 266359 |
| TEVA-TECNAL | 50MG 330MG 40MG | TABLET | Discontinued | 2025-05-28 | 2025-05-28 | 258471 |
| TEVA-TECNAL | 330MG 40MG 50MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258478 |
| TEVA-TECNAL C 1/2 | 50MG 330MG 30MG 40MG | CAPSULE | Discontinued | 2025-05-28 | 2025-05-28 | 258462 |